Retatrutide and Tirzepatide Lead Future Weight Loss Drug Innovations | Retatrutide News

Retatrutide and tirzepatide are projected to be leading weight loss drugs by 2026. These drugs, developed by Eli Lilly, are part of the GLP-1 agonist cl...
Market News · October 11, 2026